tv3326 has been researched along with tacrine in 5 studies
Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (tacrine) | Trials (tacrine) | Recent Studies (post-2010) (tacrine) |
---|---|---|---|---|---|
15 | 0 | 11 | 2,141 | 161 | 643 |
Protein | Taxonomy | tv3326 (IC50) | tacrine (IC50) |
---|---|---|---|
Chain A, ACETYLCHOLINESTERASE | Tetronarce californica (Pacific electric ray) | 0.0082 | |
Solute carrier family 22 member 2 | Homo sapiens (human) | 0.68 | |
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.1401 | |
Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.1691 | |
Amyloid-beta precursor protein | Homo sapiens (human) | 0.0456 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.7875 | |
Cytochrome P450 2E1 | Homo sapiens (human) | 0.075 | |
Cholinesterase | Homo sapiens (human) | 0.0545 | |
Acyl-CoA desaturase 1 | Rattus norvegicus (Norway rat) | 0.047 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.517 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 6.6 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 6.6 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 6.6 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.1084 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 6.6 | |
Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.0457 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.3 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 6.6 | |
Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.0457 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.078 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.1957 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.0835 | |
Amine oxidase [flavin-containing] A | Bos taurus (cattle) | 0.047 | |
Acetylcholinesterase | Mus musculus (house mouse) | 0.1143 | |
Acetylcholinesterase | Homo sapiens (human) | 0.2576 | |
Acetylcholinesterase | Bos taurus (cattle) | 0.1848 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.517 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.1143 | |
Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.2097 | |
Small conductance calcium-activated potassium channel protein 3 | Rattus norvegicus (Norway rat) | 0.042 | |
Cholinesterase | Equus caballus (horse) | 0.1103 | |
Histamine N-methyltransferase | Rattus norvegicus (Norway rat) | 0.11 | |
Cholinesterase | Mus musculus (house mouse) | 0.0625 | |
Acetylcholine receptor subunit epsilon | Homo sapiens (human) | 0.044 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 6.3 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 6.3 | |
Acyl-CoA:cholesterol acyltransferase | Oryctolagus cuniculus (rabbit) | 0.267 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.1 | |
Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | 0.0995 | |
Carboxylic ester hydrolase | Equus caballus (horse) | 0.0143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
Chen, J; Chen, X; Huang, L; Li, X; Sun, Y | 1 |
Kumar, A; Mishra, P; Panda, G | 1 |
do Carmo Carreiras, M; Ismaili, L; Marco-Contelles, J | 1 |
Blaikie, L; Kay, G; Kong Thoo Lin, P | 1 |
4 review(s) available for tv3326 and tacrine
Article | Year |
---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Ligands; Neuroprotective Agents | 2019 |
Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Cholinesterases; Humans; Ligands; Monoamine Oxidase; Neuroprotective Agents; Oxidative Stress; Pargyline; Propylamines | 2020 |
Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands.
Topics: | 2019 |
1 other study(ies) available for tv3326 and tacrine
Article | Year |
---|---|
Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Cholinesterase Inhibitors; Cholinesterases; Electrophorus; Humans; Isoflavones; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Swine; Tacrine | 2013 |